Medprin Historical Income Statement

301033 Stock

44.99 0.72 1.58%

Historical analysis of Medprin Regenerative income statement accounts such as Interest Income of 2.3 M, Selling General Administrative of 39.6 M or Total Revenue of 179.7 M can show how well Medprin Regenerative Medical performed in making a profits. Evaluating Medprin Regenerative income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Medprin Regenerative's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Medprin Regenerative latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medprin Regenerative is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medprin Regenerative Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Medprin Income Statement Analysis

Medprin Regenerative Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Medprin Regenerative shareholders. The income statement also shows Medprin investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Medprin Regenerative Income Statement Chart

At present, Medprin Regenerative's Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Reconciled Depreciation is expected to grow to about 30.6 M, whereas Tax Provision is forecasted to decline to about 6.1 M.

Tax Provision Selling General Administrative Total Revenue Gross Profit

Add Fundamental

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Medprin Regenerative generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Medprin Regenerative Medical minus its cost of goods sold. It is profit before Medprin Regenerative operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Medprin Regenerative's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Medprin Regenerative current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medprin Regenerative Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024	2025 (projected)
Gross Profit	164.0M	189.3M	217.7M	149.6M
Total Revenue	195.3M	230.9M	265.5M	179.7M

Gross Profit Total Revenue

Medprin Regenerative income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Selling General Administrative	Total Revenue	Gross Profit	Operating Income	Net Income From Continuing Ops	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Net Income	Minority Interest	Interest Expense
Tax Provision		0.6	0.69	0.84	0.83	0.82	0.97	0.97	0.71	0.86	0.88	0.79	0.78	0.98	0.97	0.33	0.75
Net Interest Income	0.6		0.0	0.21	0.1	0.08	0.42	0.49	-0.07	0.17	0.18	0.03	0.11	0.52	0.49	-0.18	0.01
Interest Income	0.69	0.0		0.76	0.87	0.87	0.8	0.7	0.78	0.72	0.85	0.87	0.98	0.7	0.69	0.64	0.92
Selling General Administrative	0.84	0.21	0.76		0.95	0.95	0.92	0.9	0.93	0.95	0.95	0.94	0.85	0.89	0.9	0.61	0.89
Total Revenue	0.83	0.1	0.87	0.95		1.0	0.94	0.85	0.92	0.94	1.0	1.0	0.91	0.85	0.85	0.7	0.98
Gross Profit	0.82	0.08	0.87	0.95	1.0		0.93	0.84	0.92	0.94	0.99	1.0	0.91	0.84	0.84	0.71	0.98
Operating Income	0.97	0.42	0.8	0.92	0.94	0.93		0.95	0.82	0.92	0.97	0.91	0.87	0.96	0.95	0.53	0.88
Net Income From Continuing Ops	0.97	0.49	0.7	0.9	0.85	0.84	0.95		0.82	0.92	0.89	0.82	0.8	1.0	1.0	0.29	0.75
Research Development	0.71	-0.07	0.78	0.93	0.92	0.92	0.82	0.82		0.96	0.91	0.93	0.83	0.8	0.82	0.52	0.86
Ebitda	0.86	0.17	0.72	0.95	0.94	0.94	0.92	0.92	0.96		0.95	0.93	0.8	0.92	0.92	0.46	0.85
Cost Of Revenue	0.88	0.18	0.85	0.95	1.0	0.99	0.97	0.89	0.91	0.95		0.99	0.9	0.89	0.89	0.65	0.96
Total Operating Expenses	0.79	0.03	0.87	0.94	1.0	1.0	0.91	0.82	0.93	0.93	0.99		0.9	0.82	0.82	0.72	0.98
Reconciled Depreciation	0.78	0.11	0.98	0.85	0.91	0.91	0.87	0.8	0.83	0.8	0.9	0.9		0.8	0.8	0.62	0.94
Income Before Tax	0.98	0.52	0.7	0.89	0.85	0.84	0.96	1.0	0.8	0.92	0.89	0.82	0.8		1.0	0.3	0.75
Net Income	0.97	0.49	0.69	0.9	0.85	0.84	0.95	1.0	0.82	0.92	0.89	0.82	0.8	1.0		0.29	0.75
Minority Interest	0.33	-0.18	0.64	0.61	0.7	0.71	0.53	0.29	0.52	0.46	0.65	0.72	0.62	0.3	0.29		0.8
Interest Expense	0.75	0.01	0.92	0.89	0.98	0.98	0.88	0.75	0.86	0.85	0.96	0.98	0.94	0.75	0.75	0.8

Click cells to compare fundamentals

Medprin Regenerative Account Relationship Matchups

Medprin Regenerative income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Tax Provision	6.1M	6.9M	4.2M	7.1M	8.2M	6.1M
Net Interest Income	24.3K	(215.8K)	(583.9K)	(344.4K)	(309.9K)	(325.4K)
Interest Income	150.0K	394.3K	989.7K	1.9M	2.2M	2.3M
Selling General Administrative	28.7M	33.5M	57.1M	53.7M	61.8M	39.6M
Total Revenue	123.5M	153.8M	195.3M	230.9M	265.5M	179.7M
Gross Profit	103.1M	126.7M	164.0M	189.3M	217.7M	149.6M
Operating Income	34.9M	37.5M	33.1M	45.2M	52.0M	38.7M
Net Income From Continuing Ops	36.9M	44.7M	35.7M	40.9M	47.0M	40.9M
Research Development	16.3M	25.9M	30.6M	26.8M	30.8M	25.9M
Cost Of Revenue	20.4M	27.1M	31.2M	41.5M	47.8M	30.1M
Total Operating Expenses	88.7M	116.3M	162.1M	185.7M	213.5M	141.0M
Reconciled Depreciation	5.0M	8.2M	15.2M	25.3M	29.1M	30.6M
Income Before Tax	43.0M	51.6M	40.0M	48.0M	55.2M	47.0M
Net Income	37.0M	44.7M	35.9M	40.9M	47.0M	40.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Other Information on Investing in Medprin Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medprin Historical Income Statement

About Medprin Income Statement Analysis

Medprin Regenerative Income Statement Chart

Tax Provision

Total Revenue

Gross Profit

Medprin Regenerative income statement Correlations

Medprin Regenerative Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medprin Regenerative income statement Accounts

Also Currently Popular

Other Information on Investing in Medprin Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Gross Profit
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops

Minority Interest	- 0.18	Net Interest Income
Research Development	- 0.07	Net Interest Income
Interest Income	- 0.0	Net Interest Income